Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation

Published:2014-10 Issue:10 Volume:20 Page:1618-1625
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Oran Betul,Kongtim Piyanuch,Popat Uday^ORCID,de Lima Marcos,Jabbour Elias,Lu Xinyan,Chen Julien,Rondon Gabriella,Kebriaei Partow,Ahmed Sairah,Andersson Borje,Alousi Amin,Ciurea Stefan,Shpall Elizabeth,Champlin Richard E.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference28 articles.

1. Myelodysplastic syndrome;Hofmann;Annu Rev Med,2005

2. Treatment of preleukemic syndromes with marrow transplantation;Appelbaum;Blood,1987

3. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia;Sierra;Blood,2002

5. The World Health Organization (WHO) classification of the myeloid neoplasms;Vardiman;Blood,2002

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the pre-transplantation serum ferritin level and outcomes of hematopoietic stem cell transplantation: A systematic review and meta-analysis;Heliyon;2024-09

2. WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients;Annals of Hematology;2024-07-06

3. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

4. Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Patients;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT;Annals of Hematology;2023-11-08